NAMI Advocacy Actions

NAMI works with policymakers to advance priority issues and ensure that the voice of people affected by mental illness is considered in policymaking. Read NAMI’s recent letters to federal leaders, submitted comments and testimony and other resources.


 
Letter to PBM on Medication Access
04/28/2021
Letter to Express Scripts, expressing concern regarding Express Scripts’ 2021 National Preferred Formulary Exclusion List placement of Parkinson’s and tardive dyskinesia medications.
Statement on Mental Health Funding
04/27/2021
Statement calling on states to take advantage of new federal funding for community-based mental health services.
Letter to Congressional Committee Leadership on Child and Adolescent Mental Health
04/26/2021
Letter to Appropriations Committee Leadership, requesting $606M to fund the Safe Schools National Activities Program and $300M for the State Personnel Development Grants to help address the shortage of school-based mental health professionals.
Letter to Congressional Committee Leadership on Health Coverage
04/26/2021
Letter to Appropriations Committee Leadership, expressing support of funding for Consumer Assistance Programs (CAPs) in the FY 2022 Labor, Health and Human Services, Education, and Related Agencies appropriations bill.
Letter to President Biden on Health Coverage & COVID-19
04/23/2021
Letter to President Biden, urging the enactment of policy change that will help support the health and wellbeing of the American public.
Letter to Congressional Leadership on Health Coverage & COVID-19
04/23/2021
Letter to Congressional leadership, urging Congress to enact additional legislation that will help support the health and wellbeing of the American public while also slowing the spread of the COVID-19 virus, particularly among vulnerable populations.
Advocacy Resource on Parity and Appealing Denial of Coverage
04/22/2021
Resource guide for peers and families released in partnership with The Kennedy Forum on how to appeal denial of coverage for mental health or substance use condition treatment.
Statement on COVID-19 and Vaccinations for People with SMI
04/15/2021
Joint statement with mental health community partners on the need for a national strategy to maximize COVID-19 vaccination for people with serious mental illness.
Letter To Congressional Committee Leadership On Nomination of Chiquita Brooks-LaSure
04/15/2021
Letter to Senate Finance Committee Leadership, expressing support for the nomination of Chiquita Brooks-LaSure as the next Administrator of the Centers for Medicare & Medicaid Services (CMS).
Letter to CDC Director on COVID-19
04/15/2021
Letter to CDC Director Walensky, urging the CDC to add schizophrenia-spectrum disorders and related disorders to the list of underlying conditions eligible for the COVID-19 vaccine.
Displaying results 31-40 (of 105)
 <  1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10  >